(-0.46%) 5 048.42 points
(-0.98%) 38 086 points
(-0.64%) 15 612 points
(0.29%) $83.81
(-1.10%) $1.620
(0.10%) $2 344.80
(0.43%) $27.47
(0.71%) $927.00
(-0.27%) $0.932
(-0.25%) $10.96
(-0.40%) $0.799
(-0.16%) $92.17
-0.55% KRW 19 770
Live Chart Being Loaded With Signals
Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage products for the treatment of cancer; SPJ1604 and SPJ003 clinical phase products for the treatment of cancer and diabetes; and SJP1901, SJP1902, SJP1801, and SJP006 biological testing stage products for the treatment of cancer, fibrosis, cancer immunotherapy, alzheimer's disease, Parkinson's disease, and anti-viral disease...
Stats | |
---|---|
Today's Volume | 28 587.00 |
Average Volume | 26 534.00 |
Market Cap | 252.56B |
EPS | KRW0 ( 2024-03-12 ) |
Next earnings date | ( KRW0 ) 2024-05-12 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW27.30 (0.14%) |
Volume Correlation
Samjin Pharmaceuticals Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Samjin Pharmaceuticals Correlation - Currency/Commodity
Samjin Pharmaceuticals Financials
Annual | 2023 |
Revenue: | KRW292.13B |
Gross Profit: | KRW145.89B (49.94 %) |
EPS: | KRW1 459.66 |
Q4 | 2023 |
Revenue: | KRW77.20B |
Gross Profit: | KRW38.53B (49.91 %) |
EPS: | KRW577.37 |
Q3 | 2023 |
Revenue: | KRW71.82B |
Gross Profit: | KRW29.40B (40.93 %) |
EPS: | KRW245.57 |
Q2 | 2023 |
Revenue: | KRW73.08B |
Gross Profit: | KRW27.44B (37.55 %) |
EPS: | KRW62.40 |
Financial Reports:
No articles found.
Samjin Pharmaceuticals
Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage products for the treatment of cancer; SPJ1604 and SPJ003 clinical phase products for the treatment of cancer and diabetes; and SJP1901, SJP1902, SJP1801, and SJP006 biological testing stage products for the treatment of cancer, fibrosis, cancer immunotherapy, alzheimer's disease, Parkinson's disease, and anti-viral disease. The company was founded in 1968 and is headquartered in Seoul, South Korea.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators